Noninterventional Study (NIS) in Patients With Bipolar Disorder (Manic or Mixed Episodes) and Schizophrenia Undergoing Treatment With Zeldox [ziprasidone].
Phase of Trial: Phase IV
Latest Information Update: 21 Aug 2009
At a glance
- Drugs Ziprasidone (Primary)
- Indications Bipolar I disorders; Bipolar II disorders; Schizophrenia
- Focus Therapeutic Use
- Sponsors Pfizer
- 21 Aug 2009 Actual number of patients changed from 460 to 471 as reported by ClinicalTrials.gov.
- 19 Jun 2008 Status changed from recruiting to completed according to clinicaltrials.gov.
- 11 Jan 2008 Status changed from initiated to recruiting.